Boston Scientific Scores Big Win In Patent Dispute

Law360, New York (May 30, 2006, 12:00 AM EDT) -- A federal appeals court gave Boston Scientific Corporation the green light to take a bite out of the multi-billion dollar U.S. market for drug-coated coronary stents last week when it affirmed two lower court rulings holding that Boston Scientific’s stents did not infringe on four patents held by Medtronic Inc.

A ruling against Boston Scientific would have left Johnson & Johnson as the sole distributor of drug-eluting stents in the U.S. But Friday's decision by the Court of Appeals for the Federal Circuit cleared the way...
To view the full article, register now.